Location History:
- Yehud, IL (2015 - 2018)
- Tel Aviv, IL (2013 - 2023)
Company Filing History:
Years Active: 2013-2025
Title: Liat Dassa: Innovator in Anti-PVRIG Antibodies
Introduction
Liat Dassa is a prominent inventor based in Tel Aviv, Israel, recognized for his significant contributions to biomedicine. With a remarkable portfolio of 19 patents, Dassa has made strides in the development of therapeutic antibodies. His expertise lies in creating innovative solutions that address critical medical challenges.
Latest Patents
Among his latest innovations are the anti-PVRIG antibodies and methods of use. This groundbreaking invention focuses on the use of anti-PVRIG antibodies for therapeutic purposes, showcasing Dassa’s commitment to pushing the boundaries of medical research and treatment methodologies.
Career Highlights
Liat Dassa currently works at Compugen Ltd., a leading biotechnology company known for its pioneering research in drug discovery. His role contributes to the company’s mission of developing novel therapies that target cancer and autoimmune diseases. Dassa's extensive patent portfolio reflects his innovative approach and dedication to enhancing healthcare solutions.
Collaborations
Throughout his career, Dassa has collaborated with notable colleagues such as Mark Leslie White and Sandeep Kumar. These partnerships have facilitated a dynamic exchange of ideas and expertise, further enhancing the impact of their research and inventions in the field of biotechnology.
Conclusion
In summary, Liat Dassa stands out as a key figure in the realm of medical innovations, particularly in the development of anti-PVRIG antibodies. His work at Compugen Ltd. and ongoing collaborations underscore his commitment to advancing biotherapeutics, marking him as a valuable contributor to the scientific community.